Cargando…

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy

Phosphoserine aminotransferase 1 (PSAT1) may be an oncogene that plays an important role in various cancer types. However, there are still many gaps in the expression of PSAT1 gene and its biological impact in different types of tumors. Here, we performed an integrated pan-cancer analysis to explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Mingtao, Cui, Huanhuan, Tu, Wenjing, Li, Liangdong, Gao, Yang, Chen, Lei, Li, Deheng, Chen, Xin, Xu, Fengfeng, Zhou, Changshuai, Cao, Yiqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465327/ https://www.ncbi.nlm.nih.gov/pubmed/36105075 http://dx.doi.org/10.3389/fgene.2022.975381

Ejemplares similares

Preoperative neutrophil-to-lymphocyte ratio (preNLR) for the assessment of tumor characteristics in lung adenocarcinoma patients with brain metastasis
por: Cui, Huanhuan, et al.
Publicado: (2022)

Prognosis and Immunological Characteristics of PGK1 in Lung Adenocarcinoma: A Systematic Analysis
por: Yang, Yuechao, et al.
Publicado: (2022)

Secreted phosphoprotein 1 promotes angiogenesis of glioblastoma through upregulating PSMA expression via transcription factor HIF1α: SPP1 promotes angiogenesis of glioblastoma
por: Tu, Wenjing, et al.
Publicado: (2022)

Dysregulation of lncRNA‐CCRR contributes to brain metastasis of breast cancer by intercellular coupling via regulating connexin 43 expression
por: Li, Deheng, et al.
Publicado: (2021)

Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer
por: Li, Liangdong, et al.
Publicado: (2021)

LINC01393, a Novel Long Non-Coding RNA, Promotes the Cell Proliferation, Migration and Invasion through MiR-128-3p/NUSAP1 Axis in Glioblastoma
por: Li, Deheng, et al.
Publicado: (2023)

Long noncoding RNA LINC00346 promotes glioma cell migration, invasion and proliferation by up‐regulating ROCK1
por: Chen, Xin, et al.
Publicado: (2020)

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
por: Li, Hetong, et al.
Publicado: (2022)

Downregulation of LINC01140 is associated with adverse features of breast cancer
por: Li, Deheng, et al.
Publicado: (2020)

Circular RNA SERPINE2 promotes development of glioblastoma by regulating the miR-361-3p/miR-324-5p/BCL2 signaling pathway
por: Li, Deheng, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022)

The clinical application of (68)Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer
por: Pei, Yuchen, et al.
Publicado: (2023)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

KIF3C Promotes Proliferation, Migration, and Invasion of Glioma Cells by Activating the PI3K/AKT Pathway and Inducing EMT
por: Gao, Yang, et al.
Publicado: (2020)

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
por: Zhang, Chi, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
por: Zhao, Yaqi, et al.
Publicado: (2022)

Juvenile-onset PSAT1-related neuropathy: A milder phenotype of serine deficiency disorder
por: Shen, Yu, et al.
Publicado: (2022)

Prognostic values of SNAI family members in breast cancer patients
por: Li, Deheng, et al.
Publicado: (2020)

An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer
por: Cong, Fengyun, et al.
Publicado: (2022)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022)

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
por: Zhang, Wenqing, et al.
Publicado: (2023)

PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Deng, Mingxia, et al.
Publicado: (2021)

A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
por: Liu, Xin, et al.
Publicado: (2022)

Biomarker Categorization in Transcriptomic Meta-Analysis by Concordant Patterns With Application to Pan-Cancer Studies
por: Ye, Zhenyao, et al.
Publicado: (2021)

Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis
por: Fu, Chenkun, et al.
Publicado: (2023)

Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
por: Zhu, Hua, et al.
Publicado: (2021)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer
por: Cao, Li, et al.
Publicado: (2022)

Age Is Important for the Early-Stage Detection of Breast Cancer on Both Transcriptomic and Methylomic Biomarkers
por: Feng, Xin, et al.
Publicado: (2019)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker
por: Fang, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5q8r6hmct9ah46mho10doh9jvs